Literature DB >> 9468274

Myeloid-specific gene expression.

S Clarke1, S Gordon.   

Abstract

The mononuclear phagocytes are recruited from bone marrow precursors to most tissues of the body, particularly during inflammation or immune stimulation. This combination of accessibility as stem cells and heterogenity of tissue locations makes the myeloid cell potentially important as a carrier of therapeutic agents. Understanding the regulation of transcription in myeloid cells is necessary for any future design of tissue-specific gene targeting vectors, particularly if there are inherent size limitations. Identified members of the C/EBP, Runt/PEBP2/CBF, and Ets families of transcription factors are critical for myeloid-specific gene expression and may have myeloid-restricted expression or myeloid-specific regulation in the hematopoietic system. AP-1, Sp1, and Myb appear to be important for myeloid-restricted expression in some cases. In addition, factors involved in the up-regulation of the level of gene expression when macrophages are activated by agents such as interferon-gamma and bacterial products have been identified. Some of the sequences to which these transcription factors bind in myeloid-restricted genes have been tested in cell lines and in transgenic mice and it is now possible to make an attempt to describe the characteristics of a myeloid-specific promoter.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9468274     DOI: 10.1002/jlb.63.2.153

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  15 in total

1.  The pattern of gene expression in human CD15+ myeloid progenitor cells.

Authors:  S Lee; G Zhou; T Clark; J Chen; J D Rowley; S M Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

2.  Activated Fes protein tyrosine kinase induces terminal macrophage differentiation of myeloid progenitors (U937 cells) and activation of the transcription factor PU.1.

Authors:  Jynho Kim; Ricardo A Feldman
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

Review 3.  Macrophage-specific gene expression: current paradigms and future challenges.

Authors:  David R Greaves; Siamon Gordon
Journal:  Int J Hematol       Date:  2002-07       Impact factor: 2.490

4.  The air-liquid interface and use of primary cell cultures are important to recapitulate the transcriptional profile of in vivo airway epithelia.

Authors:  Alejandro A Pezzulo; Timothy D Starner; Todd E Scheetz; Geri L Traver; Ann E Tilley; Ben-Gary Harvey; Ronald G Crystal; Paul B McCray; Joseph Zabner
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-10-22       Impact factor: 5.464

5.  PDE1B2 regulates cGMP and a subset of the phenotypic characteristics acquired upon macrophage differentiation from a monocyte.

Authors:  Andrew T Bender; Joseph A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-03       Impact factor: 11.205

6.  Hematopoietic cell populations in dolphin bone marrow: Analysis of colony formation and differentiation.

Authors:  Takao Segawa; Takuya Itou; Miwa Suzuki; Tadaaki Moritomo; Teruyuki Nakanishi; Takeo Sakai
Journal:  Results Immunol       Date:  2011-05-17

7.  TIF1beta functions as a coactivator for C/EBPbeta and is required for induced differentiation in the myelomonocytic cell line U937.

Authors:  J W Rooney; K L Calame
Journal:  Genes Dev       Date:  2001-11-15       Impact factor: 11.361

8.  Conditional gene targeting in macrophages and granulocytes using LysMcre mice.

Authors:  B E Clausen; C Burkhardt; W Reith; R Renkawitz; I Förster
Journal:  Transgenic Res       Date:  1999-08       Impact factor: 2.788

9.  The use of human CD68 transcriptional regulatory sequences to direct high-level expression of class A scavenger receptor in macrophages in vitro and in vivo.

Authors:  P J Gough; S Gordon; D R Greaves
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

10.  Initial description of the human NLRP3 promoter.

Authors:  J P Anderson; J L Mueller; A Misaghi; S Anderson; M Sivagnanam; R D Kolodner; H M Hoffman
Journal:  Genes Immun       Date:  2008-08-21       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.